Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Bio Blast Pharma Ltd (NASDAQ:ORPN)

6.48
Delayed Data
As of Jul 31
 -0.16 / -2.41%
Today’s Change
4.50
Today|||52-Week Range
11.00
+1.41%
Year-to-Date
No recent news for Bio Blast Pharma Ltd.

Today’s Trading

Previous close6.64
Today’s open6.62
Day’s range6.34 - 6.67
Volume30,973
Average volume (3 months)34,774
Market cap$92.2M
Dividend yield--
Data as of 3:59pm ET, 07/31/2015

Growth & Valuation

Earnings growth (last year)-307.14%
Earnings growth (this year)-121.93%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratio--
Price/Sales--
Price/Book3.01

Competitors

 Today’s
change
Today’s
% change
PTIEPain Therapeutics In...+0.13+7.39%
ADMAADMA Biologics Inc+0.34+3.79%
CFRXContraFect Corp-0.03-0.61%
HSGXHistogenics Corp+0.34+5.72%
Data as of 3:59pm ET, 07/31/2015

Financials

Next reporting dateAugust 28, 2015
EPS forecast (this quarter)-$0.28
Annual revenue (last year)$0.00
Annual profit (last year)-$7.0M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Colin J. Foster
Chief Financial Officer &
Director
Ehud-Moshe Gilboa
Corporate headquarters
Tel Aviv, Tel Aviv

Forecasts